Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

Condition:   SmallpoxIntervention:   Biological: MVA-BN® smallpox vaccineSponsor:   Bavarian NordicRecruiting - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials